ZELDESMERAN
UNII BD2KE88JH4

Substance Identification & Data

This profile provides standardized clinical and technical data for Zeldesmeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BD2KE88JH4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2726459-47-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BD2KE88JH4
CAS Registry Number
2726459-47-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZELDESMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203100
National Cancer Institute reference terminology for clinical and research data.
INN ID
12547
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zeldesmeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELDESMERAN

Common Names & Synonyms

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED VERSION OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (BASED UPON GENBANK ID: MT270101.1), CONTAINING THE D614G MUTATION, FLANKED BY A 5' UNTRANSLATED REGION (5'UTR) DERIVED FROM THE 5'UTR OF TOBACCO ETCH VIRUS AND A 3' UNTRANSLATED REGION (3'UTR) DERIVED FROM THE 3'UTR OF XENOPUS LAEVIS BETA GLOBIN MRNA, AND TERMINATED WITH A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN (614-GLYCINE)-SPECIFYING PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER PTX-COVID19-B), INNER SALT
ZELDESMERAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus